| Literature DB >> 35350755 |
Yuanhan Zhu1, Yulin Sun1, Jichao Hu2, Zhuoer Pan2.
Abstract
Exercise preconditioning has attracted extensive attention to induce endogenous neuroprotection and has become the hotspot in neurotherapy. The training exercise is given multiple times before cerebral ischemia, effectively inducing ischemic tolerance and alleviating secondary brain damage post-stroke. Compared with other preconditioning methods, the main advantages of exercise include easy clinical operation and being readily accepted by patients. However, the specific mechanism behind exercise preconditioning to ameliorate brain injury is complex. It involves multi-pathway and multi-target regulation, including regulation of inflammatory response, oxidative stress, apoptosis inhibition, and neurogenesis promotion. The current review summarizes the recent studies on the mechanism of neuroprotection induced by exercise, providing the theoretical basis of applying exercise therapy to prevent and treat ischemic stroke. In addition, we highlight the various limitations and future challenges of translational medicine from fundamental study to clinical application.Entities:
Keywords: apoptosis; exercise preconditioning; ischemic stroke; neuroinflammation; neurprotection; oxidative stress
Year: 2022 PMID: 35350755 PMCID: PMC8957886 DOI: 10.3389/fphar.2022.866360
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
Summary of pre-clinical studies of exercise preconditioning in ischemic stroke.
| Exercise type | Exercise manner | Species and model | Outcome | Involved signal | References |
|---|---|---|---|---|---|
| treadmill exercise | 10 min/day (15–25 m/min), 5 days/week for 3 weeks | male Sprague–Dawley rats, 60 min of MCAO | reduced infarct volume and ameliorated sensorimotor function | upregulate BDNF, HIF-1α, and P2X7 receptor |
|
| treadmill exercise or swimming | Swim or run (15 m/min) 30 min/day, 5 days/week for 3 weeks | male Wistar rats, 30 min of MCAO | Increase brain trophic support and reduce brain damage | Increase the gene expressions of TrkB, TNF-α, and MMP2 |
|
| treadmill exercise | 4 weeks, the distance of exercise per week is about 5,000 m | male Sprague-Dawley rats, 90 min of MCAO | improve neurocognitive function | Increase the basal dopamine level |
|
| treadmill exercise | 25 min/day for 4 days, break for 2 days, and one acute bout for 30 min | male Wistar rats, embolic stroke model | reduce the neurovascular injury and improved functional outcomes | Increase the expression of peNOS and pAMPK |
|
| treadmill exercise | 30 min/day (2 m/min for the first 5 min, 3 m/min for the next 5 min, 5 m/min for the last 20 min) for 4 weeks | male Wistar rats, bilateral common carotid arteries occlusion | ameliorate shot-term memory impairment and prevent microvascular injury in the hippocampus | prevente the reduction of ZO-1 in the hippocampus and inhibite the activation of MMP-9 |
|
| treadmill exercise | 30 min (20 m/min), 30 min (30 m/min) and 60 min (30 m/min) for 1 week each | male Sprague-Dawley rats, MCAO | attenuate neurological injury | preserve old and newly formed HSP72-containing neurons |
|
| treadmill exercise | 30 min/day (25 m/min) for 3 or 5 days/week for 3 weeks | male Sprague-Dawley rats, 60 min of MCAO | reduce infarct volumes, improve neurological scores and sensorimotor function | reduce the Bax/Bcl-2 ratio and caspase-3 activation |
|
| treadmill exercise | 30 min/day (25 m/min) for 5 days/week for 3 weeks | male Sprague-Dawley rats, 60 min of MCAO | reduce ischemic neuronal cell death, induce neuron- and astrocyte-mediated brain ischemic tolerance | Increase expression of HIF-1α, and inhibit 14-3-3γ/p-β-catenin Ser37 anti-apoptotic pathway |
|
| treadmill exercise | 30 min/day for 5 days/week for 8 weeks | male Wistar rats, 60 min of MCAO | improve neurological function and BBB integrity | develop higher levels of cortical VEGF-A and striatal VEGF-R2 |
|
| treadmill exercise | 40 min/day (18 m/min) for 5 days/week for 4 weeks | ovariectomized mice, permanent MCAO | diminish infarct volume, and improve neurological deficits | Decrease MMP-9, and increase IL-10 |
|
| treadmill exercise | 5 days/week for 4 weeks, time and intensity increase progressively | male wistar rats, 60 min of MCAO | reduce brain edema and decrease the neurological movement disorders | none |
|
| treadmill exercise | 30 min/day (15 m/min) for 3 days/week for 4.5 weeks | male C57Bl/6 mice, 13 min of global cerebral ischemia | forced treadmill exercise induce a stress response, and lead to increased neuronal damage | Increase levels of NLRP3, galectin-3, IFNγ and IL-10 |
|
| treadmill exercise | 30 min/day (20 m/min) for 6 days/week | male Sprague Dawley rats, 90 min of MCAO | reduce brain infarct volume and neurological deficits | Increase SOD activity and decrease the concentration of MDA |
|
| treadmill exercise | 30 min/day (15 m/min) for 6 days/week for 3 weeks | male Sprague Dawley rats, 120 min of MCAO | improve neurological deficits, reduce infarct volume, mitigate pathological damage in the ischemic cortex | regulation of the TLR4/NF-κB signaling pathway and the inhibition of central and peripheral inflammatory cascades |
|
| treadmill exercise | 30 min/day (25 m/min) for 5 days/week for 3 weeks | male Sprague Dawley rats, 60 min of MCAO | reduce neuronal apoptosis, oxidative stress, and infract volume, ameliorate motor function, increase astrocyte proliferation and angiogenesis | enhance expression of MK and BDNF |
|
| treadmill exercise | 30 min (20 m/min), 30 min (30 m/min) and 60 min (30 m/min) for 1 week each | male Sprague Dawley rats, 90 min of MCAO | attenuate brain infarct, glial apoptosis, and neurological deficits | Increase the numbers of both the HSP20-containing neurons and the HSP20-containing glia |
|
| swimming | 60 min/day for 6 days/week for 4 weeks | Sprague Dawley rats, 120 min of MCAO | reduce infarct volume | upregulate the expression of HIF-1α |
|
| treadmill exercise | 30 min/day (20 m/min) for 6 days/week for 3 weeks | male Sprague Dawley rats, 120 min of MCAO | reduce brain infarct volume, cerebral edema and neurological deficits | regulation of PKC-α-GLT-1-Glutamate and PI3K/Akt-GLT-1-Glutamate signal pathway |
|
| treadmill exercise | 30 min/day (20 m/min) for 5 days/week for 2 weeks | male Sprague Dawley rats, 120 min of MCAO | improve CBF and neurologic deficits, reduce infarct volume | Decrease ET-1 expression |
|
| treadmill exercise | 30 min/day (18 m/min) for 5 days/week for 3 weeks | male wistar rats, 10 min of 4-vessel occlusion model | improve behavioral functions and maintain more viable cells in the dorsal hippocampus | none |
|
| treadmill exercise | 30 min/day (30 m/min) for 5 days/week for 3 weeks | male Sprague Dawley rats, 120 min of MCAO | reduce neurological deficit and infarct volume, increase the rates of glucose metabolism | reduce ADP/ATP ratio, increase GLUT1, GLUT3, and PFK |
|
| treadmill exercise | 30 min/day (30 m/min) for 5 days/week for 3 weeks | Sprague Dawley rats, MCAO | reduce neuronal apoptosis | inhibit the expression of MMP-9 and ERK1/2 expression |
|
| treadmill exercise | 30 min/day (30 m/min) for 5 days/week for 3 weeks | Sprague Dawley rats, MCAO | diminish neuronal injury, reduce infarct volume | upregulate HSP-70, ERK 1/2 and Bcl-x(L), downregulate Bax and AIF |
|
| treadmill exercise | 30 min/day (30 m/min) for 5 days/week for 3 weeks | male Sprague Dawley rats, 120 min of MCAO | Decrease neurological deficits, infarct volume and leukocyte infiltration | Reduce TNF-α, ERK 1/2, MMP-9 and ICDM-1 expression |
|
BBB, blood-brain barrier; BDNF, brain-derived neurotrophic factor; CBF, cerebral blood flow; ERK1/2, extracellular signal-regulated kinase one and 2; GLT-1, glutamate transporter-1; HIF-1α, hypoxia-inducible factor-1α; HSP, heat shock protein; ICDM-1, intercellular adhesion molecule-1; MCAO, middle cerebral artery occlusion; MDA, malondialdehyde; MK, midkine; MMP, matrix metalloproteinase-9; NF-κB, nuclear transcription factor-κB; NLRP3, nucleotide-binding oligomerization domain-like receptor containing pyrin domain 3; peNOS, phosphorylated endothelial nitric oxide synthase; SOD, superoxide dismutase; TLR4, toll-like receptor-4; TNF-α, tumour necrosis factor-α; TrkB, tropomyosin receptor kinase B; VEGF-A, vascular endothelial g PKC-α, protein kinase C-α; rowth factor A; VEGF-R2, vascular endothelial growth factor receptor 2; ZO-1, zonula occludens-1.
FIGURE 1The involved mechanisms underlying preconditioning exercise-induced neuroprotection in ischmeic stroke.